메뉴 건너뛰기




Volumn 1862, Issue 2, 2017, Pages 188-195

Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c

Author keywords

Antioxidative activity; Functionality; HDL; Lipidomics; Type 2 diabetes

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN 3C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; SPHINGOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

EID: 84998828092     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.10.014     Document Type: Article
Times cited : (35)

References (37)
  • 1
    • 4444382796 scopus 로고    scopus 로고
    • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
    • [1] Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:9438 (2004), 937–952.
    • (2004) Lancet , vol.364 , Issue.9438 , pp. 937-952
    • Yusuf, S.1    Hawken, S.2    Ounpuu, S.3    Dans, T.4    Avezum, A.5    Lanas, F.6
  • 2
    • 0034700631 scopus 로고    scopus 로고
    • The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease
    • [2] Maron, D.J., The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am. J. Cardiol. 86:12A (2000), 11L–14L.
    • (2000) Am. J. Cardiol. , vol.86 , Issue.12A , pp. 11L-14L
    • Maron, D.J.1
  • 3
    • 0035806916 scopus 로고    scopus 로고
    • Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study
    • [3] Sharrett, A.R., Ballantyne, C.M., Coady, S.A., Heiss, G., Sorlie, P.D., Catellier, D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study. Circulation 104:10 (2001), 1108–1113.
    • (2001) Circulation , vol.104 , Issue.10 , pp. 1108-1113
    • Sharrett, A.R.1    Ballantyne, C.M.2    Coady, S.A.3    Heiss, G.4    Sorlie, P.D.5    Catellier, D.6
  • 4
    • 1542361567 scopus 로고    scopus 로고
    • Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update
    • [4] Gotto, A.M. Jr., Brinton, E.A., Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J. Am. Coll. Cardiol. 43:5 (2004), 717–724.
    • (2004) J. Am. Coll. Cardiol. , vol.43 , Issue.5 , pp. 717-724
    • Gotto, A.M.1    Brinton, E.A.2
  • 5
    • 84949672279 scopus 로고    scopus 로고
    • HDL particle number and size as predictors of cardiovascular disease
    • [5] Kontush, A., HDL particle number and size as predictors of cardiovascular disease. Front. Pharmacol., 6, 2015, 218.
    • (2015) Front. Pharmacol. , vol.6 , pp. 218
    • Kontush, A.1
  • 6
    • 84888203299 scopus 로고    scopus 로고
    • Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities
    • [6] Camont, L., Lhomme, M., Rached, F., Le Goff, W., Negre-Salvayre, A., Salvayre, R., et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler. Thromb. Vasc. Biol. 33:12 (2013), 2715–2723.
    • (2013) Arterioscler. Thromb. Vasc. Biol. , vol.33 , Issue.12 , pp. 2715-2723
    • Camont, L.1    Lhomme, M.2    Rached, F.3    Le Goff, W.4    Negre-Salvayre, A.5    Salvayre, R.6
  • 7
    • 80053574090 scopus 로고    scopus 로고
    • Biological activities of HDL subpopulations and their relevance to cardiovascular disease
    • [7] Camont, L., Chapman, M.J., Kontush, A., Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol. Med. 17:10 (2011), 594–603.
    • (2011) Trends Mol. Med. , vol.17 , Issue.10 , pp. 594-603
    • Camont, L.1    Chapman, M.J.2    Kontush, A.3
  • 8
    • 33644608784 scopus 로고    scopus 로고
    • Antiatherogenic small, dense HDL—guardian angel of the arterial wall?
    • [8] Kontush, A., Chapman, M.J., Antiatherogenic small, dense HDL—guardian angel of the arterial wall?. Nat. Clin. Pract. Cardiovasc. Med. 3:3 (2006), 144–153.
    • (2006) Nat. Clin. Pract. Cardiovasc. Med. , vol.3 , Issue.3 , pp. 144-153
    • Kontush, A.1    Chapman, M.J.2
  • 9
    • 84930741855 scopus 로고    scopus 로고
    • HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export
    • [9] Du, X.M., Kim, M.J., Hou, L., Le Goff, W., Chapman, M.J., Van Eck, M., et al. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ. Res. 116:7 (2015), 1133–1142.
    • (2015) Circ. Res. , vol.116 , Issue.7 , pp. 1133-1142
    • Du, X.M.1    Kim, M.J.2    Hou, L.3    Le Goff, W.4    Chapman, M.J.5    Van Eck, M.6
  • 11
    • 16844382469 scopus 로고    scopus 로고
    • Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia
    • [11] Nobecourt, E., Jacqueminet, S., Hansel, B., Chantepie, S., Grimaldi, A., Chapman, M.J., et al. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia 48:3 (2005), 529–538.
    • (2005) Diabetologia , vol.48 , Issue.3 , pp. 529-538
    • Nobecourt, E.1    Jacqueminet, S.2    Hansel, B.3    Chantepie, S.4    Grimaldi, A.5    Chapman, M.J.6
  • 12
    • 40749106651 scopus 로고    scopus 로고
    • Why is HDL functionally deficient in type 2 diabetes?
    • [12] Kontush, A., Chapman, M.J., Why is HDL functionally deficient in type 2 diabetes?. Curr. Diab. Rep. 8:1 (2008), 51–59.
    • (2008) Curr. Diab. Rep. , vol.8 , Issue.1 , pp. 51-59
    • Kontush, A.1    Chapman, M.J.2
  • 13
    • 84871995815 scopus 로고    scopus 로고
    • Standards of medical care in diabetes—2013
    • [13] American, D.A., Standards of medical care in diabetes—2013. Diabetes Care 36:Suppl. 1 (2013), S11–S66.
    • (2013) Diabetes Care , vol.36 , pp. S11-S66
    • American, D.A.1
  • 15
    • 0027285970 scopus 로고
    • Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects
    • [15] Lagrost, L., Gandjini, H., Athias, A., Guyard-Dangremont, V., Lallemant, C., Gambert, P., Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler. Thromb. 13:6 (1993), 815–825.
    • (1993) Arterioscler. Thromb. , vol.13 , Issue.6 , pp. 815-825
    • Lagrost, L.1    Gandjini, H.2    Athias, A.3    Guyard-Dangremont, V.4    Lallemant, C.5    Gambert, P.6
  • 16
    • 0020523662 scopus 로고
    • Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats
    • [16] Blank, M.L., Hall, M.N., Cress, E.A., Snyder, F., Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem. Biophys. Res. Commun. 113:2 (1983), 666–671.
    • (1983) Biochem. Biophys. Res. Commun. , vol.113 , Issue.2 , pp. 666-671
    • Blank, M.L.1    Hall, M.N.2    Cress, E.A.3    Snyder, F.4
  • 17
    • 0019486232 scopus 로고
    • A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
    • [17] Chapman, M.J., Goldstein, S., Lagrange, D., Laplaud, P.M., A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22:2 (1981), 339–358.
    • (1981) J. Lipid Res. , vol.22 , Issue.2 , pp. 339-358
    • Chapman, M.J.1    Goldstein, S.2    Lagrange, D.3    Laplaud, P.M.4
  • 18
    • 0029941224 scopus 로고    scopus 로고
    • Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia
    • [18] Guerin, M., Bruckert, E., Dolphin, P.J., Turpin, G., Chapman, M.J., Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 16:6 (1996), 763–772.
    • (1996) Arterioscler. Thromb. Vasc. Biol. , vol.16 , Issue.6 , pp. 763-772
    • Guerin, M.1    Bruckert, E.2    Dolphin, P.J.3    Turpin, G.4    Chapman, M.J.5
  • 19
    • 0036269506 scopus 로고    scopus 로고
    • Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux
    • [19] Guerin, M., Egger, P., Soudant, C., Le Goff, W., van Tol, A., Dupuis, R., et al. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Atherosclerosis 163:2 (2002), 287–296.
    • (2002) Atherosclerosis , vol.163 , Issue.2 , pp. 287-296
    • Guerin, M.1    Egger, P.2    Soudant, C.3    Le Goff, W.4    van Tol, A.5    Dupuis, R.6
  • 20
    • 6344267152 scopus 로고    scopus 로고
    • Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity
    • [20] Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M.J., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J. Clin. Endocrinol. Metab. 89:10 (2004), 4963–4971.
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , Issue.10 , pp. 4963-4971
    • Hansel, B.1    Giral, P.2    Nobecourt, E.3    Chantepie, S.4    Bruckert, E.5    Chapman, M.J.6
  • 21
    • 24644514986 scopus 로고    scopus 로고
    • A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity
    • [21] Kontush, A., de Faria, E.C., Chantepie, S., Chapman, M.J., A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 182:2 (2005), 277–285.
    • (2005) Atherosclerosis , vol.182 , Issue.2 , pp. 277-285
    • Kontush, A.1    de Faria, E.C.2    Chantepie, S.3    Chapman, M.J.4
  • 22
    • 0028883658 scopus 로고
    • Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
    • [22] Abbott, C.A., Mackness, M.I., Kumar, S., Boulton, A.J., Durrington, P.N., Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15:11 (1995), 1812–1818.
    • (1995) Arterioscler. Thromb. Vasc. Biol. , vol.15 , Issue.11 , pp. 1812-1818
    • Abbott, C.A.1    Mackness, M.I.2    Kumar, S.3    Boulton, A.J.4    Durrington, P.N.5
  • 23
    • 39449100874 scopus 로고    scopus 로고
    • Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity
    • [23] de Souza, J.A., Vindis, C., Hansel, B., Negre-Salvayre, A., Therond, P., Serrano, C.V. Jr., et al. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis 197:1 (2008), 84–94.
    • (2008) Atherosclerosis , vol.197 , Issue.1 , pp. 84-94
    • de Souza, J.A.1    Vindis, C.2    Hansel, B.3    Negre-Salvayre, A.4    Therond, P.5    Serrano, C.V.6
  • 24
    • 74549148035 scopus 로고    scopus 로고
    • Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
    • [24] Chapman, M.J., Le Goff, W., Guerin, M., Kontush, A., Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur. Heart J. 31:2 (2010), 149–164.
    • (2010) Eur. Heart J. , vol.31 , Issue.2 , pp. 149-164
    • Chapman, M.J.1    Le Goff, W.2    Guerin, M.3    Kontush, A.4
  • 25
    • 79960614571 scopus 로고    scopus 로고
    • Atlanta GUSDoHaHS. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States
    • Centers for Disease Control and Prevention
    • [25] Centers for Disease Control and Prevention, Atlanta GUSDoHaHS. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. 2011, Centers for Disease Control and Prevention.
    • (2011)
    • Centers for Disease Control and Prevention1
  • 26
    • 0034673999 scopus 로고    scopus 로고
    • The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study
    • [26] Curtiss, L.K., Bonnet, D.J., Rye, K.A., The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry 39:19 (2000), 5712–5721.
    • (2000) Biochemistry , vol.39 , Issue.19 , pp. 5712-5721
    • Curtiss, L.K.1    Bonnet, D.J.2    Rye, K.A.3
  • 27
    • 33646531407 scopus 로고    scopus 로고
    • Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation
    • [27] Persegol, L., Verges, B., Foissac, M., Gambert, P., Duvillard, L., Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia 49:6 (2006), 1380–1386.
    • (2006) Diabetologia , vol.49 , Issue.6 , pp. 1380-1386
    • Persegol, L.1    Verges, B.2    Foissac, M.3    Gambert, P.4    Duvillard, L.5
  • 28
    • 0035962077 scopus 로고    scopus 로고
    • Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial
    • [28] Robins, S.J., Collins, D., Wittes, J.T., Papademetriou, V., Deedwania, P.C., Schaefer, E.J., et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 285:12 (2001), 1585–1591.
    • (2001) JAMA , vol.285 , Issue.12 , pp. 1585-1591
    • Robins, S.J.1    Collins, D.2    Wittes, J.T.3    Papademetriou, V.4    Deedwania, P.C.5    Schaefer, E.J.6
  • 29
    • 84910024203 scopus 로고    scopus 로고
    • Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation
    • [29] Gomez Rosso, L., Lhomme, M., Merono, T., Sorroche, P., Catoggio, L., Soriano, E., et al. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation. Atherosclerosis 237:2 (2014), 652–660.
    • (2014) Atherosclerosis , vol.237 , Issue.2 , pp. 652-660
    • Gomez Rosso, L.1    Lhomme, M.2    Merono, T.3    Sorroche, P.4    Catoggio, L.5    Soriano, E.6
  • 30
    • 84883732971 scopus 로고    scopus 로고
    • Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles
    • [30] Stahlman, M., Fagerberg, B., Adiels, M., Ekroos, K., Chapman, J.M., Kontush, A., et al. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles. Biochim. Biophys. Acta 1831:11 (2013), 1609–1617.
    • (2013) Biochim. Biophys. Acta , vol.1831 , Issue.11 , pp. 1609-1617
    • Stahlman, M.1    Fagerberg, B.2    Adiels, M.3    Ekroos, K.4    Chapman, J.M.5    Kontush, A.6
  • 31
    • 84876740446 scopus 로고    scopus 로고
    • Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study
    • [31] Wong, V.W., Tse, C.H., Lam, T.T., Wong, G.L., Chim, A.M., Chu, W.C., et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study. PLoS One, 8(4), 2013, e62885.
    • (2013) PLoS One , vol.8 , Issue.4 , pp. e62885
    • Wong, V.W.1    Tse, C.H.2    Lam, T.T.3    Wong, G.L.4    Chim, A.M.5    Chu, W.C.6
  • 32
    • 84884678009 scopus 로고    scopus 로고
    • Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes
    • [32] Meikle, P.J., Wong, G., Barlow, C.K., Weir, J.M., Greeve, M.A., MacIntosh, G.L., et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One, 8(9), 2013, e74341.
    • (2013) PLoS One , vol.8 , Issue.9 , pp. e74341
    • Meikle, P.J.1    Wong, G.2    Barlow, C.K.3    Weir, J.M.4    Greeve, M.A.5    MacIntosh, G.L.6
  • 33
    • 84931572631 scopus 로고    scopus 로고
    • The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics
    • [33] Lappas, M., Mundra, P.A., Wong, G., Huynh, K., Jinks, D., Georgiou, H.M., et al. The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics. Diabetologia 58:7 (2015), 1436–1442.
    • (2015) Diabetologia , vol.58 , Issue.7 , pp. 1436-1442
    • Lappas, M.1    Mundra, P.A.2    Wong, G.3    Huynh, K.4    Jinks, D.5    Georgiou, H.M.6
  • 34
    • 79952836464 scopus 로고    scopus 로고
    • A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking
    • [34] Boslem, E., MacIntosh, G., Preston, A.M., Bartley, C., Busch, A.K., Fuller, M., et al. A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem. J. 435:1 (2011), 267–276.
    • (2011) Biochem. J. , vol.435 , Issue.1 , pp. 267-276
    • Boslem, E.1    MacIntosh, G.2    Preston, A.M.3    Bartley, C.4    Busch, A.K.5    Fuller, M.6
  • 35
    • 84923886912 scopus 로고    scopus 로고
    • Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine
    • [35] Manukyan, L., Ubhayasekera, S.J., Bergquist, J., Sargsyan, E., Bergsten, P., Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine. Endocrinology 156:3 (2015), 802–812.
    • (2015) Endocrinology , vol.156 , Issue.3 , pp. 802-812
    • Manukyan, L.1    Ubhayasekera, S.J.2    Bergquist, J.3    Sargsyan, E.4    Bergsten, P.5
  • 36
    • 84864396455 scopus 로고    scopus 로고
    • Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction
    • [36] Boslem, E., Meikle, P.J., Biden, T.J., Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction. Islets 4:3 (2012), 177–187.
    • (2012) Islets , vol.4 , Issue.3 , pp. 177-187
    • Boslem, E.1    Meikle, P.J.2    Biden, T.J.3
  • 37
    • 73749083481 scopus 로고    scopus 로고
    • Global estimates of the prevalence of diabetes for 2010 and 2030
    • [37] Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87:1 (2010), 4–14.
    • (2010) Diabetes Res. Clin. Pract. , vol.87 , Issue.1 , pp. 4-14
    • Shaw, J.E.1    Sicree, R.A.2    Zimmet, P.Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.